The Group's principal activity is to manufacture generic drugs. The Group operates through two core segments: Generics and Branded products. Through Generics segment, the Group offers medicines after the expiration of their patents at the same quality but for significantly lower prices. Through Branded Products segment, the Group focuses on multisource products with off-patent active ingredients. The Group's current branded products portfolio includes primarily non-prescription which are called over-the-counter products (OTC products), and in some national markets also prescription drugs. The non-core segment includes commercial business. The Group mainly operates in Europe, America and Asia.
Alacra Alerts:
Receive alerts on the latest reports on STADA Arzneimittel AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
